返回 
加入收藏
10省（区、市）医保目录收载治疗精神障碍药物类基本药物的情况分析
x
请在关注微信后，向客服人员索取文件
| 篇名： | 10省（区、市）医保目录收载治疗精神障碍药物类基本药物的情况分析 |
| TITLE： | |
| 摘要： | 目的：为促进基本药物优先使用、优化医保目录对治疗精神障碍药物的遴选提供参考。方法：登陆北京、上海、天津、浙江、海南、青海、新疆、山西、辽宁、湖北10省（区、市）人力资源和社会保障厅（局）网站，下载其最新版医保目录，对其中治疗精神障碍药物（包含22种国家基本药物品种）的收载情况进行统计和分析。结果：10省（区、市）医保目录收载治疗精神障碍药物品规数在80～88个之间，平均82.7个。22个品种、29个品规治疗精神障碍药物类基本药物在10省（区、市）医保目录中均全部收载，其中列为甲类药品规数最多的是北京，有25个，占86.2％；其次是上海，有23个，占79.3％；其他地区皆为17个，均占58.6％。除北京、上海外，其他地区医保目录均未将第二代抗精神病药类基本药物利培酮片列为甲类药。另外，各省（区、市）医保目录收载的抗躁狂药类基本药物仅有碳酸锂片1个品规。结论：2012年版国家基本药物目录的出台，对精神障碍疾病的治疗起到较好的保障作用，但也存在部分类别如抗躁狂药品规较少等不足。尽管10省（区、市）医保目录对治疗精神障碍药物类基本药物均全部收载，但也存在地区间不平衡、第二代抗精神病药列为甲类药少等问题。故两个目录仍有待进一步优化和完善。 |
| ABSTRACT： | OBJECTIVE： To provide reference for promoting the prior usage of essential medicines and scientifically selecting of antipsychotic medicines in the national and local health insurance directory. METHODS： Entering the Human Resources and Social Security Bureau websites in 10 provinces （autonomous regions or municipalities） （Beijing， Shanghai， Tianjin， Zhejiang， Hainan， Qinghai， Xinjiang， Shanxi， Liaoning， Hubei）， health insurance directory was downloaded to statistically analyze the containing antipsychotic medicines （including 22 national essential medicines）. RESULTS： In antipsychotic medicines， there were 80-88 varieties in the 10 provinces （autonomous regions or municipalities）， with an average of 82.7. 22 essential medicines including 29 specifications were totally recorded by the 10 provinces， of which Beijing had 25 specifications in class A， which had the most specifications， accounting for 86.2％； followed by Shanghai， 23 specifications in class A， accounting for 79.3％； there were only 17 specifications in class A in other areas， accounting for 58.6％. In addition to Beijing and Shanghai， Risperidone tablet was not contained in class A， which was secondary generation antipsychotic drug. In addition， there was only one specification of Lithium carbonate in the antimanic drugs. CONCLUSIONS： The National essential medicine list （2012 edition） is assured for mental disorder in clinical treatment. However， there were some deficiencies such as lack of antimanic drugs. Even though all of antipsychotic essential medicines were contained in 10 provinces， many problems were exposed such as regional imbalance and less secondary generation antipsychotic drug in class A. Therefore， the two lists still need further optimization and improvement. |
| 期刊： | 2017年第28卷第3期 |
| 作者： | 彭洪兴，高明泽 |
| AUTHORS： | PENG Hongxing，GAO Mingze |
| 关键字： | 治疗精神障碍药物；国家基本药物目录；医保目录；收载 |
| KEYWORDS： | Drugs for the treatment of mental disorders； National essential medicine list； Health insurance directory； Record |
| 阅读数： | 782 次 |
| 本月下载数： | 13 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
